« Previous
Next »
Fertility and Sterility
Volume 92, Issue 3
, Pages 907-912
, September 2009
Comparison of low-dose human menopausal gonadotropin and micronized 17β-estradiol supplementation in in vitro maturation cycles with thin endometrial lining
References
- . In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994;62:353–362
- Fertility preservation treatment for young women with autoimmune disease facing treatment with gonadotoxic agents. Rheumatology. 2008;in press
- Immature oocyte retrieval in the luteal phase to preserve fertility in women with cancer facing imminent gonadotoxic therapy: it is worth a try. Reprod Biomed Online. 2008;in press
- Obstetric outcomes following vitrification of in-vitro and in-vivo matured oocytes. Fertil Steril. 2008;in press
- Live birth after vitrification of in vitro matured human oocytes. Fertil Steril. 2008;in press
- . Fertility preservation in women undergoing cancer treatment. Lancet. 2004;363:1829–1830
- . In vitro maturation (IVM) of ocytes from unstimulated normal ovaries of women with previous poor response to IVF. Fertil Steril. 2000;74(Suppl 1):s45
- . In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertil Steril. 2007;88:62–67
- . Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med. 1999;341(1624):6
- . Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program. Fertil Steril. 2003;79:656–658
- . In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol. 2002;186:684–689
- . Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod. 2000;15:165–170
- . Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online. 2006;13:340–348
- . Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes. Hum Reprod. 2007;22:1991–1995
- . Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2005;83:336–340
- . Predicting factors for endometrial thickness during treatment with assisted reproductive technology. Fertil Steril. 2007;87:799–804
- . Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril. 2000;73:106–113
- . The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update. 1996;2:323–335
- . Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles. Hum Reprod. 1992;7:677–680
- . Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertil Steril. 1996;65:262–266
- Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist. Fertil Steril. 2008;89:998–1001
- Comparison of cycles programmed for IVM with and without in vivo matured oocytes retrieved. Reprod Biomed Online. 2008;in press
- . Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998;83:3984–3991
- . In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:597–600
S.E.E. has nothing to disclose. W.-Y.S. has nothing to disclose. R.Y. has nothing to disclose. Y.G. has nothing to disclose. D.L. has nothings to disclose. E.D. has nothing to disclose. S.-L-T. has nothing to disclose.
PII: S0015-0282(08)03270-6
doi: 10.1016/j.fertnstert.2008.07.1750
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 92, Issue 3
, Pages 907-912
, September 2009

